QQ客服 官方微博 反馈留言

	Discovery of N-phenyl)-2-phenyl)acetamide as a Potent FMS-like Tyrosine Kinase 3 Internal Tandem Duplication Mutant Selective Inhibitor for Acute Myeloid Leukemia
	Wang, Beilei; Li, Feng; Liu, Qingwang; Hu, Zhenquan; Liang, Xiaofei; Yu, Kailin; Chen, Cheng; Hu, Chen; Zou, Fengming; Wang, Aoli
刊名	JOURNAL OF MEDICINAL CHEMISTRY
	2019
卷号	Vol.62 No.2页码:875-892
ISSN号	0022-2623
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2205803
专题	安徽大学
作者单位	1.Chinese Acad Sci, Hefei Inst Phys Sci, Inst Technol Innovat, Precis Targeted Therapy Discovery Ctr, Hefei 230088, Anhui, Peoples R China 2.Univ Sci & Technol China, Hefei 230036, Anhui, Peoples R China 3.Anhui Med Univ, Dept Hematol, Affiliated Hosp 1, Hefei 230022, Anhui, Peoples R China 4.Precis Med Res Lab Anhui Prov, Hefei 230088, Anhui, Peoples R China 5.Chinese Acad Sci, Hefei Inst Phys Sci, Key Lab High Magnet Field & Ion Beam Phys Biol, High Magnet Field Lab, Hefei 230031, Anhui, Peoples R China 6.Anhui Univ, Inst Phys Sci & Informat Technol, Hefei 230601, Anhui, Peoples R China 7.Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02115 USA
推荐引用方式 GB/T 7714	Wang, Beilei,Li, Feng,Liu, Qingwang,et al. Discovery of N-phenyl)-2-phenyl)acetamide as a Potent FMS-like Tyrosine Kinase 3 Internal Tandem Duplication Mutant Selective Inhibitor for Acute Myeloid Leukemia[J]. JOURNAL OF MEDICINAL CHEMISTRY,2019,Vol.62 No.2:875-892.
APA	Wang, Beilei.,Li, Feng.,Liu, Qingwang.,Hu, Zhenquan.,Liang, Xiaofei.,...&Wang, Aoli.(2019).Discovery of N-phenyl)-2-phenyl)acetamide as a Potent FMS-like Tyrosine Kinase 3 Internal Tandem Duplication Mutant Selective Inhibitor for Acute Myeloid Leukemia.JOURNAL OF MEDICINAL CHEMISTRY,Vol.62 No.2,875-892.
MLA	Wang, Beilei,et al."Discovery of N-phenyl)-2-phenyl)acetamide as a Potent FMS-like Tyrosine Kinase 3 Internal Tandem Duplication Mutant Selective Inhibitor for Acute Myeloid Leukemia".JOURNAL OF MEDICINAL CHEMISTRY Vol.62 No.2(2019):875-892.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。